complex for improving, alleviating, treating or preventing of hyperlipidemia

摘要

PURPOSE: A single tablet containing a first composition containing rosuvastatin calcium salt and anhydrous dibasic calcium phosphate and a second composition containing fenofibric acid calcium salt is provided to stabilize rosuvastatin calcium salt and sample bioavailability with conventional fenofibrate formulation and rosuvastatin calcium salt formulation. CONSTITUTION: A single tablet for preventing and treating lipid metabolic disorders contains a first composition containing rosuvastatin calcium salt and anhydrous dibasic calcium phosphate and a second composition containing fenofibric acid calcium salt. The second composition contains hydroxyl propyl methyl cellulose and enteric polymers. The enteric polymer is polymethacrylate.